Comparison of Bone Mineral Loss in Prostate Cancer Patients Who is Receiving GnRH Agonist and -Plus Anti-androgen Agent

Clinical trial NCT01303692 · COMPLETED

Trial details

NCT number: NCT01303692
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

GnRH Agonist Alone vs. GnRH Agonist Plus Anti-androgen Combination Treated Prostate Cancer Patients

Start date: 2011-04-01
Primary completion: 2014-02-01
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.